Finally, the protective effects of pregnancy on MS relapse have led to the extensive focus on the estrogen receptor (ER) and its ligands as a means for promoting remyelination (Xiao et al., 2012; Moore et al., 2014; Najm et al., 2015; Itoh et al., 2017). Here, ESR1 is linked to myeloid sarcoma.